Annual CFF
$404.60 K
+$2.53 M+119.02%
December 31, 2023
Summary
- As of February 8, 2025, LPCN annual cash flow from financing activities is $404.60 thousand, with the most recent change of +$2.53 million (+119.02%) on December 31, 2023.
- During the last 3 years, LPCN annual CFF has fallen by -$20.49 million (-98.06%).
- LPCN annual CFF is now -99.17% below its all-time high of $48.48 million, reached on December 31, 2013.
Performance
LPCN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$0.00
-$217.40 K-100.00%
September 30, 2024
Summary
- As of February 8, 2025, LPCN quarterly cash flow from financing activities is $0.00, with the most recent change of -$217.40 thousand (-100.00%) on September 30, 2024.
- Over the past year, LPCN quarterly CFF has increased by +$5300.00 (+100.00%).
- LPCN quarterly CFF is now -100.00% below its all-time high of $35.94 million, reached on September 30, 2013.
Performance
LPCN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$204.00 K
-$421.10 K-67.37%
September 30, 2024
Summary
- As of February 8, 2025, LPCN TTM cash flow from financing activities is $204.00 thousand, with the most recent change of -$421.10 thousand (-67.37%) on September 30, 2024.
- Over the past year, LPCN TTM CFF has dropped by -$200.60 thousand (-49.58%).
- LPCN TTM CFF is now -99.58% below its all-time high of $48.48 million, reached on December 31, 2013.
Performance
LPCN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
LPCN Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +119.0% | +100.0% | -49.6% |
| 3 y3 years | -98.1% | +100.0% | +1293.0% |
| 5 y5 years | -96.2% | +100.0% | +1293.0% |
LPCN Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -98.5% | +119.0% | -100.0% | +100.0% | -99.2% | +105.4% |
| 5 y | 5-year | -98.5% | +119.0% | -100.0% | +100.0% | -99.5% | +105.4% |
| alltime | all time | -99.2% | +119.0% | -100.0% | +100.0% | -99.6% | +105.4% |
Lipocine Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(-100.0%) | $204.00 K(-67.4%) |
| Jun 2024 | - | $217.40 K(-2784.0%) | $625.10 K(+55.3%) |
| Mar 2024 | - | -$8100.00(+52.8%) | $402.50 K(-0.5%) |
| Dec 2023 | $404.60 K(-119.0%) | -$5300.00(-101.3%) | $404.60 K(+0.1%) |
| Sep 2023 | - | $421.10 K(-8198.1%) | $404.00 K(-2462.6%) |
| Jun 2023 | - | -$5200.00(-13.3%) | -$17.10 K(-98.9%) |
| Mar 2023 | - | -$6000.00(+1.7%) | -$1.51 M(-29.2%) |
| Dec 2022 | -$2.13 M(-107.9%) | -$5900.00(<-9900.0%) | -$2.13 M(-28.1%) |
| Sep 2022 | - | $0.00(-100.0%) | -$2.96 M(-22.1%) |
| Jun 2022 | - | -$1.49 M(+138.1%) | -$3.80 M(+20.8%) |
| Mar 2022 | - | -$627.30 K(-25.2%) | -$3.14 M(-111.7%) |
| Dec 2021 | $26.92 M(+28.8%) | -$838.50 K(+0.0%) | $26.92 M(-16.7%) |
| Sep 2021 | - | -$838.30 K(-0.0%) | $32.32 M(-14.5%) |
| Jun 2021 | - | -$838.60 K(-102.8%) | $37.82 M(-16.8%) |
| Mar 2021 | - | $29.44 M(+546.3%) | $45.46 M(+117.5%) |
| Dec 2020 | $20.90 M(+102.5%) | $4.56 M(-2.3%) | $20.90 M(-5.7%) |
| Sep 2020 | - | $4.66 M(-31.4%) | $22.16 M(+27.9%) |
| Jun 2020 | - | $6.80 M(+39.4%) | $17.32 M(+73.8%) |
| Mar 2020 | - | $4.88 M(-16.1%) | $9.97 M(-3.4%) |
| Dec 2019 | $10.32 M(-3.1%) | $5.81 M(-3451.4%) | $10.32 M(+103.7%) |
| Sep 2019 | - | -$173.50 K(-68.6%) | $5.07 M(-5.0%) |
| Jun 2019 | - | -$552.10 K(-110.6%) | $5.33 M(-9.4%) |
| Mar 2019 | - | $5.23 M(+831.3%) | $5.88 M(-44.8%) |
| Dec 2018 | $10.65 M | $561.60 K(+518.5%) | $10.65 M(+5.1%) |
| Sep 2018 | - | $90.80 K(>+9900.0%) | $10.14 M(-18.5%) |
| Jun 2018 | - | $0.00(-100.0%) | $12.43 M(-31.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $10.00 M(>+9900.0%) | $18.14 M(+61.6%) |
| Dec 2017 | $11.23 M(+1752.8%) | $46.20 K(-98.1%) | $11.23 M(-4.5%) |
| Sep 2017 | - | $2.38 M(-58.2%) | $11.75 M(+25.5%) |
| Jun 2017 | - | $5.71 M(+85.0%) | $9.37 M(+156.1%) |
| Mar 2017 | - | $3.09 M(+440.0%) | $3.66 M(+503.9%) |
| Dec 2016 | $605.90 K(-98.1%) | $571.60 K(>+9900.0%) | $605.80 K(+1671.3%) |
| Sep 2016 | - | $0.00(0.0%) | $34.20 K(-62.7%) |
| Jun 2016 | - | $0.00(-100.0%) | $91.80 K(-99.7%) |
| Mar 2016 | - | $34.20 K(>+9900.0%) | $32.61 M(-0.3%) |
| Dec 2015 | $32.72 M(<-9900.0%) | $0.00(-100.0%) | $32.72 M(0.0%) |
| Sep 2015 | - | $57.60 K(-99.8%) | $32.72 M(+0.2%) |
| Jun 2015 | - | $32.52 M(>+9900.0%) | $32.66 M(>+9900.0%) |
| Mar 2015 | - | $136.90 K(>+9900.0%) | $153.00 K(-160.0%) |
| Dec 2014 | -$255.10 K(-100.5%) | $0.00(0.0%) | -$255.10 K(-102.1%) |
| Sep 2014 | - | $0.00(-100.0%) | $12.28 M(-74.5%) |
| Jun 2014 | - | $16.10 K(-105.9%) | $48.22 M(+0.0%) |
| Mar 2014 | - | -$271.20 K(-102.2%) | $48.20 M(-0.6%) |
| Dec 2013 | $48.48 M(>+9900.0%) | $12.54 M(-65.1%) | $48.48 M(+34.7%) |
| Sep 2013 | - | $35.94 M(>+9900.0%) | $35.98 M(>+9900.0%) |
| Jun 2013 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2013 | - | $0.00(-100.0%) | $40.50 K(0.0%) |
| Dec 2012 | $40.50 K(+34.1%) | $40.50 K(-200.0%) | $40.50 K(>+9900.0%) |
| Sep 2012 | - | -$40.50 K(-200.0%) | $0.00(-100.0%) |
| Jun 2012 | - | $40.50 K(>+9900.0%) | $40.50 K(>+9900.0%) |
| Mar 2012 | - | $0.00 | $0.00 |
| Dec 2011 | $30.20 K | - | - |
FAQ
- What is Lipocine annual cash flow from financing activities?
- What is the all time high annual CFF for Lipocine?
- What is Lipocine annual CFF year-on-year change?
- What is Lipocine quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Lipocine?
- What is Lipocine quarterly CFF year-on-year change?
- What is Lipocine TTM cash flow from financing activities?
- What is the all time high TTM CFF for Lipocine?
- What is Lipocine TTM CFF year-on-year change?
What is Lipocine annual cash flow from financing activities?
The current annual CFF of LPCN is $404.60 K
What is the all time high annual CFF for Lipocine?
Lipocine all-time high annual cash flow from financing activities is $48.48 M
What is Lipocine annual CFF year-on-year change?
Over the past year, LPCN annual cash flow from financing activities has changed by +$2.53 M (+119.02%)
What is Lipocine quarterly cash flow from financing activities?
The current quarterly CFF of LPCN is $0.00
What is the all time high quarterly CFF for Lipocine?
Lipocine all-time high quarterly cash flow from financing activities is $35.94 M
What is Lipocine quarterly CFF year-on-year change?
Over the past year, LPCN quarterly cash flow from financing activities has changed by +$5300.00 (+100.00%)
What is Lipocine TTM cash flow from financing activities?
The current TTM CFF of LPCN is $204.00 K
What is the all time high TTM CFF for Lipocine?
Lipocine all-time high TTM cash flow from financing activities is $48.48 M
What is Lipocine TTM CFF year-on-year change?
Over the past year, LPCN TTM cash flow from financing activities has changed by -$200.60 K (-49.58%)